International Patent: SHORT INTERFERING NUCLEIC ACID MOLECULE FOR THE TREATMENT OF TIMOTHY SYNDROME TYPE 1 ASSOCIATED WITH MUTATIONS IN THE ALPHA SUBUNIT OF THE L-TYPE CALCIUM CHANNEL GENE

GENEVA, July 1 -- ISTITUTI CLINICI SCIENTIFICI MAUGERI S.P.A. S.B. filed a patent application (IT2025/050291) for “SHORT INTERFERING NUCLEIC ACID MOLECULE FOR THE TREATMENT OF TIMOTHY SYNDROME TYPE 1 ASSOCIATED WITH MUTATIONS IN THE ALPHA SUBUNIT OF THE L-TYPE CALCIUM CHANNEL GENE”. With publication no. WO/2026/126264, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....